China-based yeast and yeast extract manufacturer Angel Yeast has officially started production at its new probiotics project in Xizang to expand R&D and local production of probiotics.
The new facility, dubbed Xizang Angel Zhufeng Biotechnology, owns full independent property rights from the key strains to production processes.
The new factory’s workshop features fully digitalised and automated equipment, fully enclosed conveying digital management, and quality tracing of all sections.
Probiotic products can be applied in the food, healthcare, agriculture industries and more, and can have great economic value and market potential, said the yeast manufacturer.
Angel Yeast’s Xizang subsidiary general manager He Xinzhang said: “For three years, the R&D team overcame altitude sickness and visited the herdsmen’s families, collected dairy products, and travelled to the high-altitude areas to chase yaks and pick up cow dung, completing a series of microbial resources census collection and evaluation works with fruitful results.
“We collected and preserved over 1,800 bacterial strains and identified the ones to be industrialised.
“Now we not only have the patent-licensed probiotic strains but also own the independent intellectual property rights of the production process, which together build up our competitive advantages in the market.”
Angel Yeast’s probiotics production is primarily focused on three industrialised strains, the Lactobacillus plantarum S2, the DB-8, and Streptococcus thermophilus.
The Lactobacillus plantarum S2 offers a strong acid-producing capacity and superior fermentation results, which can be used in food and agriculture productions.
The DB-8 is primarily applied in dairy products and can make yoghurt that offers a natural tomato flavour without additives, which provides high commercial value.
Streptococcus thermophilus can be used to maintain the taste of yoghurts, as the strain prevents the yoghurt from further acidification over time.
Furthermore, Angel Yeast aims to implement its strategic roadmap for biotechnology transformation to advance the development.
The company is developing four new biotech sectors, microorganisms, and cell cultures, biocatalysis and enzymes, biomaterials, and biotechnology services.
In addition, the yeast manufacturer is also promoting the applications of synthetic biology in the fields of healthcare, bio-agriculture, biomaterials, and other areas.
